Home
About Us
Company Introduction Development History Honors Contact Us
R&D Innovation
R&D Ecosystem Innovation Achievements Artificial Intelligence
Internationalization
Global Sales Network Coverage Overseas R&D World-Class Manufacturing System
Pipeline
Anti-infective Chronic Disease
News & Media
Company News Media Coverage
Investor
Stock Information Announcements ESG Investor Contact
Recruitment
English
中文 English
English
中文 English
Pipeline Pipeline
Pipeline

Pipeline
Ertongshu<sup>®</sup>Benzbromarone Tablet
Ertongshu®Benzbromarone Tablet

Indications:
Applicable to primary hyperuricemia and the intercritical period of gouty arthritis.

Strength:25mg、50mg

National Drug Approval Number:H20204016、H20040348

Download instruction manual
About Us
Company Introduction Development History Honors Contact Us
R&D Innovation
R&D Ecosystem Innovation Achievements Artificial Intelligence
Internationalization
Global Sales Network Coverage Overseas R&D World-Class Manufacturing System
Pipeline
Anti-infective Chronic Disease
News & Media
Company News Media Coverage
Investor
Stock Information Announcements ESG Investor Contact
Recruitment
Links
HEC Group HEC Tech HEC Fresh-Cordyceps
CopyRight © 2024 Sunshine Lake Pharma Co., Ltd. 粤ICP备2021116245号-1
东阳光集团公众号
东阳光药公众号